Details for New Drug Application (NDA): 075238
✉ Email this page to a colleague
NDA 075238 describes SOTALOL HYDROCHLORIDE, which is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Llc, Impax Pharms, Natco Pharma Usa, Oxford Pharms, Rising, Sun Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs, and is included in seventeen NDAs. It is available from eighteen suppliers. There are four patents protecting this drug. Additional details are available on the SOTALOL HYDROCHLORIDE profile page.
The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
Summary for 075238
| Tradename: | SOTALOL HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | sotalol hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075238
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
| Approval Date: | Jul 13, 2000 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 120MG | ||||
| Approval Date: | Jul 13, 2000 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 160MG | ||||
| Approval Date: | Jul 13, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
